Decisions of the annual general meeting of shareholders

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Decisions of the annual general meeting of shareholders

Nordecon AS (registry code 10099962, address Pärnu mnt 158/1, 11317 Tallinn) annual general meeting of shareholders was held on 25 May 2016 at 10.00 a.m. in the conference centre of Radisson Blu Hotel Olümpia, room Gamma (Liivalaia 33, 10118 Tallinn).

The shareholders of Nordecon AS made the following decisions according to the proposed agenda:

Item 1. Approval of the Company’s annual report 2015 and adoption of profit allocation resolution

1.1.        To approve the Company’s annual report for 2015 as submitted by the management board.

1.2.        To allocate the profit of the Company as follows: The Company’s consolidated net profit for 2015 amounts to 179 thousand euros, prior period retained earning amounts to 10,791 thousand euros and, thus, total distributable profit as at 31 December 2015 amounts to 10,970 thousand euros. To allocate 923 thousand euros (0.03 euros per share) as the profit to be distributed to the shareholders (the dividend). No appropriations shall be made to the capital reserve or other reserves provided for by the law or the articles of association. After the allocations, retained earnings will amount to 10,047 thousand euros.

Shareholders entitled to dividends include persons entered in the Company’s share register on 8 June 2016 at 11.59 pm. No dividends shall be paid to the Company for own shares, the number of eligible shares is 30,756,728. The dividends will be distributed to the shareholders on 22 June 2016 at the latest.

Item 2. Election of auditor for the financial year 2016 and deciding on the remuneration of the auditor

2.1.        To elect audit firm KPMG Baltics OÜ as the auditor of the Company for the financial year 2016 and to pay for the services according to the agreement to be signed with the auditor.

Item 3. Decrease of the share capital of the Company

3.1.        To decrease the share capital of the Company by 971,264.49 euros from 20,691,704.91 euros to 19,720,440.42 euros. The share capital will be decreased by reducing the book value of the shares by 0.03 euro. The total number of the shares will not change and the book value of shares shall be reduced proportionately to the reduction of the share capital. As a result of the decrease of the share capital, the share capital of the company will be 19,720,440.42 euros that is divided into 32,375,483 shares with book value.

3.2.        Upon decrease of the share capital to make payments to the shareholders in the amount of 0.03 euros per share, in the total amount of 922,701.84 euros. The payments to the shareholders shall be made three months after the registration of the reduction of the share capital with the commercial register.

3.3.        The share capital is decreased to improve the structure of capital in order to bring the amount of the share capital into alignment with the volume of business and strategic goals. The reduced amount of the share capital is in compliance with the requirements set out by the legislation and the articles of association.

3.4.        The list of shareholders who shall participate in the decreasing of the share capital will be fixed as of 8 June 2016 at 11:59 pm.

At the annual general meeting of shareholders 19,365,661 ordinary shares entitled to vote were represented, i.e. 62.96% of total ordinary shares outstanding.

Nordecon ( www.nordecon.com ) is a group of construction companies whose core business is construction project management and general contracting in the buildings and infrastructures segment. Geographically the Group operates in Estonia, Ukraine, Finland and Sweden. The parent of the Group is Nordecon AS, a company registered and located in Tallinn, Estonia. In addition to the parent company, there are more than 10 subsidiaries in the Group. The consolidated revenue of the Group in 2015 was 145.5 million euros. Currently Nordecon Group employs more than 650 people. Since 18 May 2006 the company's shares have been quoted in the main list of the NASDAQ OMX Tallinn Stock Exchange.

         Andri Hõbemägi          Nordecon AS          Head of Investor Relations          Tel: +372 6272 022          Email: andri.hobemagi@nordecon.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 232

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 290

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 373

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 104

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 38

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 675

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 144

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 136

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 607

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 21

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Major Bitcoin Investor Makes $696 Million Acquisition of BTC

Updated Category News Views 95

Understanding Recent Movements in Bitcoin Investment Bitcoin (BTC) continues to hover between the $62,000 and $63,000 price levels, facing challenges in surpassing the $64,000 mark. Amid this stagnant market behavior, significant interest from large-scale investors, often referred to as 'whales,' is becoming increasingly evident. These bullish activities from crypto...

Continue Reading
Nordic American Tankers Maintains Stability Amid Election Results

Updated Category News Views 133

Nordic American Tankers Shows Confidence Post Election Dear Shareholders and Investors, As we analyze the current business landscape, it is evident that Nordic American Tankers Ltd (NYSE: NAT) is navigating through these times with resilience and assurance. Regardless of the outcome of the presidential election, we foresee minimal immediate effect on our operations or...

Continue Reading
Investors Have a Unique Chance to Lead Fiserv's Securities Case

Updated Category News Views 258

Investors Encouraged to Participate in Fiserv's Legal Battle Faruqi & Faruqi, LLP is reaching out to investors who have experienced financial losses exceeding $75,000 while investing in Fiserv, Inc. This call to action invites affected investors to explore their legal rights in light of recent developments surrounding the company. Understanding the Fiserv Situation The...

Continue Reading
Exploring New Paradigms in U.S. Health and Wellness Trends

Updated Category News Views 217

Innovative Insights into the U.S. Health and Wellness Market A recent national survey, known as the WELLSurvey™, has shed light on the dynamic nature of the U.S. health and wellness market. It reveals the aspirations and attitudes of millions of American households, highlighting a growing trend toward healthier lifestyles. The survey encompasses the perspectives of...

Continue Reading
NW Natural Holdings Declares Increased Quarterly Dividend

Updated Category News Views 134

NW Natural Holdings Declares Increased Quarterly Dividend The Board of Directors of Northwest Natural Holding Company (NYSE: NWN) has officially announced a quarterly dividend of 49 cents per share on the Company's common stock. This decision reflects the company's ongoing commitment to delivering value to its shareholders while maintaining operational excellence....

Continue Reading